08143.HK
Good Fellow Healthcare Holdings Limited
HKSE · Healthcare · Medical - Care Facilities · HK
HKD 0.27
+0.00%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 30.1M | 20.1M | 16.1M | 39.0M | 55.4M |
| Cost of Revenue | 13.1M | 9.5M | 7.8M | 20.3M | 28.3M |
| Gross Profit | 11.7M | 10.6M | 8.4M | 18.7M | 27.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 17.0M | 17.0M | 18.2M | 29.2M | 37.3M |
| General & Admin Expense | 14.7M | 14.7M | 15.1M | 20.3M | 23.8M |
| Selling & Marketing Expense | 2.3M | 2.3M | 3.1M | 8.9M | 13.6M |
| Other Expenses | 12.5M | 6.8M | (2.6M) | 5.5M | (5.0M) |
| Total Operating Expenses | 29.5M | 23.8M | 15.5M | 34.7M | 32.3M |
| Cost and Expenses | 49.4M | 33.2M | 23.3M | 55.0M | 60.6M |
| Operating Income (EBIT) | (19.4M) | (13.2M) | (7.2M) | (16.0M) | (5.2M) |
| Non-Operating | |||||
| Interest Income | — | 6.0K | 1.0K | 28.0K | 448.0K |
| Interest Expense | 152.0K | 152.0K | 190.0K | 308.0K | 414.0K |
| Net Interest Income | (225.0K) | (146.0K) | (189.0K) | (280.0K) | 34.0K |
| Other Non-Op Income/Expense | 643.0K | 643.0K | (190.0K) | (308.0K) | (414.0K) |
| Non-Operating Income (excl Interest) | (3.0M) | — | — | — | — |
| EBT (Pre-Tax Income) | (18.8M) | (12.5M) | (7.4M) | (16.3M) | (5.7M) |
| Income Tax Expense | 6.0K | — | (11.0K) | 1.0M | 26.0K |
| Bottom Line | |||||
| Net Income | (17.4M) | (12.5M) | (10.1M) | (17.1M) | (5.9M) |
| Earnings from Cont. Ops | (12.5M) | (12.5M) | (7.4M) | (17.4M) | (5.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (17.4M) | (12.5M) | (10.1M) | (17.1M) | (5.9M) |
| Per Share | |||||
| Basic EPS | (HK$0.39) | (HK$0.31) | (HK$0.35) | (HK$0.75) | (HK$0.26) |
| Diluted EPS | (HK$0.39) | (HK$0.31) | (HK$0.35) | (HK$0.75) | (HK$0.26) |
| Revenue Per Share | HK$0.66 | HK$0.50 | HK$0.55 | HK$1.73 | HK$2.46 |
| Shares | |||||
| Basic Shares Outstanding | 45.3M | 40.4M | 29.1M | 22.5M | 22.5M |
| Diluted Shares Outstanding | 45.3M | 40.4M | 29.1M | 22.5M | 22.5M |
| Profitability Metrics | |||||
| EBITDA | (12.7M) | (13.1M) | 1.9M | (10.1M) | 1.8M |
| D&A | 2.0M | 86.0K | 9.0M | 5.9M | 7.1M |
| EBIT | (14.7M) | (13.2M) | (7.2M) | (16.0M) | (5.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026